AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 150 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $78,000 | -71.1% | 108,193 | -9.4% | 0.00% | – |
Q4 2021 | $270,000 | -18.7% | 119,429 | +3.7% | 0.00% | – |
Q3 2021 | $332,000 | -20.2% | 115,185 | +5.0% | 0.00% | – |
Q2 2021 | $416,000 | +10.3% | 109,729 | -1.3% | 0.00% | – |
Q1 2021 | $377,000 | +12.2% | 111,218 | -7.4% | 0.00% | – |
Q4 2020 | $336,000 | -69.6% | 120,123 | -72.8% | 0.00% | -100.0% |
Q3 2020 | $1,107,000 | -70.5% | 441,126 | +59.9% | 0.00% | -66.7% |
Q2 2020 | $3,747,000 | +108.6% | 275,948 | +16.5% | 0.00% | +50.0% |
Q1 2020 | $1,796,000 | +256.3% | 236,902 | +196.3% | 0.00% | – |
Q4 2019 | $504,000 | +180.0% | 79,952 | +72.9% | 0.00% | – |
Q3 2019 | $180,000 | -75.1% | 46,231 | -69.1% | 0.00% | – |
Q2 2019 | $723,000 | -9.3% | 149,633 | +53.3% | 0.00% | – |
Q1 2019 | $797,000 | -16.8% | 97,592 | -43.7% | 0.00% | -100.0% |
Q4 2018 | $958,000 | -82.4% | 173,269 | -71.9% | 0.00% | -50.0% |
Q3 2018 | $5,439,000 | +78.2% | 616,337 | +101.4% | 0.00% | +100.0% |
Q2 2018 | $3,052,000 | -30.6% | 306,074 | -33.7% | 0.00% | -50.0% |
Q1 2018 | $4,396,000 | +83.0% | 461,445 | +185.5% | 0.00% | 0.0% |
Q4 2017 | $2,402,000 | -42.2% | 161,640 | -23.6% | 0.00% | -33.3% |
Q3 2017 | $4,158,000 | +5.2% | 211,440 | -23.2% | 0.00% | 0.0% |
Q2 2017 | $3,953,000 | +1948.2% | 275,191 | +1201.7% | 0.00% | – |
Q1 2017 | $193,000 | -24.0% | 21,141 | -14.0% | 0.00% | – |
Q4 2016 | $254,000 | +103.2% | 24,572 | +76.6% | 0.00% | – |
Q3 2016 | $125,000 | -38.1% | 13,910 | -48.9% | 0.00% | – |
Q2 2016 | $202,000 | +17.4% | 27,195 | +41.7% | 0.00% | – |
Q1 2016 | $172,000 | -33.8% | 19,194 | -5.4% | 0.00% | – |
Q4 2015 | $260,000 | +66.7% | 20,291 | +23.8% | 0.00% | – |
Q3 2015 | $156,000 | -91.1% | 16,393 | -90.4% | 0.00% | -100.0% |
Q2 2015 | $1,761,000 | +3493.9% | 171,387 | +3780.2% | 0.00% | – |
Q1 2015 | $49,000 | -57.4% | 4,417 | -55.7% | 0.00% | – |
Q4 2014 | $115,000 | +11400.0% | 9,971 | +13748.6% | 0.00% | – |
Q3 2014 | $1,000 | 0.0% | 72 | +84.6% | 0.00% | – |
Q2 2014 | $1,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
Leap Investments LP | 54,700 | $415,000 | 0.61% |